• @silent2k
    link
    English
    21 year ago

    The clinical trials are the most costly and most risky part of development.

    • be_excellent_to_each_other
      link
      fedilink
      -21 year ago

      From the passage I already quoted:

      In reality, public sources — especially the NIH — fund the basic research that makes scientific breakthroughs. Then small, boutique biotech and pharmaceutical firms take that publicly generated knowledge and do the final stages of research, like running clinical trials, that get the drugs to market.

      • @[email protected]
        link
        fedilink
        English
        4
        edit-2
        1 year ago

        That is not true. Small biotech usually cannot effort late stage development. They either just get buyed by big pharma. Or they licence the lead compound to big pharma and get royalties. Very few exemptions to this.

        Edit: the link you provide cites this FT article as a source for this claim. However the article is about M&A and supports my point.

        • be_excellent_to_each_other
          link
          fedilink
          01 year ago

          I’ll assume you know more about this than I do despite the lack of any citation.

          I refuse to believe there’s an ethically acceptable business justification for this ridiculous markup.

          The entire healthcare industry in the US is built on a foundation of corporate greed. This is just one obvious example.